Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare ...

Indian pharma leaders emphasize the need for innovation at scale, leveraging AI and collaborations to overcome industry ...

The discussion, featuring Shanghvi alongside Aurobindo Pharma whole-time director Madan Mohan Reddy, Lupin managing director Nilesh Gupta and Zydus Lifesciences managing director Sharvil Patel, ...

Jay Bregman, CEO and co-founder of Andel, discusses how pharmaceutical companies and digital health platforms may need to rethink commercialization strategies, shifting away from costly mass-market ...

Tarsus Pharmaceuticals remains a Strong Buy, driven by Xdemvy's robust growth and management's $2B+ peak sales target. Click ...

Sandy Donaldson, co-founder and chief strategy officer at Impiricus, spoke with Pharmaceutical Executive about the state of pharma advertising. Recent regulatory conversations and ...

AbbVie (NYSE: ABBV) is a large drug company with a somewhat unusual portfolio of products, spanning immunology (Skyrizi and ...

Some of the conservative groups publicly opposing the Trump administration’s effort to force down drug prices are bankrolled by PhRMA, a trade organization with a vested interest in undoing the ...

We came across a bullish thesis on Ultragenyx Pharmaceutical Inc. on HalfBakedInnovations’s Substack by Biotech Distilled. In ...

BridgeBio Pharma (NASDAQ:BBIO) executives used the company’s fourth-quarter 2025 earnings call to highlight accelerating ...

Officials laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, ...